A federal appeals court reversed a legal win for Boston Scientific (NYSE:BSX), vacating a lower court’s ruling and remanding the case for reconsideration.
The U.S. Court of Appeals for the Federal Circuit ruled that the district court judge erred in deciding how the patents’ claims would be construed, with an "erroneously imported" limitation from 1 of the patent’s claims.